XML 41 R24.htm IDEA: XBRL DOCUMENT v3.20.2
NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
The following table provides information about disaggregated revenue by product mix

The following table provides information about disaggregated revenue by product mix for the three and nine months ended September 30, 2020 and 2019:

 

   Three Months Ended
September 30,		   Nine Months Ended
September 30,		 
   2020   2019   2020   2019 
Prescription vitamins  $2,435,903   $2,550,330   $7,337,976   $7,309,174 
IMVEXXY   6,841,592    4,772,354    18,319,382    9,904,744 
BIJUVA   1,646,320    490,705    4,109,925    624,987 
ANNOVERA   6,418,990    399,952    10,527,212    399,952 
License revenue   2,000,000    15,506,400    2,000,000    15,506,400 
Net revenue  $19,342,805   $23,719,741   $42,294,495   $33,745,257